KBLB Statistics
Total Valuation
Kraig Biocraft Laboratories has a market cap or net worth of 92.93 million. The enterprise value is 98.38 million.
| Market Cap | 92.93M |
| Enterprise Value | 98.38M |
Important Dates
The next estimated earnings date is Wednesday, November 13, 2024.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Kraig Biocraft Laboratories has 1.04 billion shares outstanding. The number of shares has increased by 1.97% in one year.
| Shares Outstanding | 1.04B |
| Shares Change (YoY) | +1.97% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 25.21% |
| Owned by Institutions (%) | n/a |
| Float | 776.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -24.67 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -62.14 |
Financial Position
The company has a current ratio of 0.17
| Current Ratio | 0.17 |
| Quick Ratio | 0.17 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.09 |
| Interest Coverage | -7.05 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -73.85% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -97,268 |
| Employee Count | 44 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +184.40% in the last 52 weeks. The beta is 0.72, so Kraig Biocraft Laboratories's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | +184.40% |
| 50-Day Moving Average | 0.09 |
| 200-Day Moving Average | 0.10 |
| Relative Strength Index (RSI) | 48.45 |
| Average Volume (20 Days) | 511,954 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.07 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.58M |
| Pretax Income | -3.99M |
| Net Income | -3.99M |
| EBITDA | -3.55M |
| EBIT | -3.58M |
| Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 1.52 million in cash and 1.73 million in debt, giving a net cash position of -203,693 or -0.00 per share.
| Cash & Cash Equivalents | 1.52M |
| Total Debt | 1.73M |
| Net Cash | -203,693 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -6.97M |
| Book Value Per Share | -0.01 |
| Working Capital | -7.61M |
Cash Flow
In the last 12 months, operating cash flow was -1.58 million and capital expenditures -6,399, giving a free cash flow of -1.58 million.
| Operating Cash Flow | -1.58M |
| Capital Expenditures | -6,399 |
| Free Cash Flow | -1.58M |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Kraig Biocraft Laboratories does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.97% |
| Shareholder Yield | -1.97% |
| Earnings Yield | -4.30% |
| FCF Yield | -1.70% |
Stock Splits
The last stock split was on May 28, 2009. It was a forward split with a ratio of 10.
| Last Split Date | May 28, 2009 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |